Age for diabetes screening should be reduced to 35: USPSTF draft recommenation
USA: The U.S. Preventive Services Task Force (USPSTF) has released a draft recommendation which proposes to lower prediabetes and type 2 diabetes' screening age of adults with obesity or overweight from 40 to 35 years.
According to the recommendations, these patients should continue to be screened for type 2 diabetes and prediabetes until they reach the age of 70 years.
The draft recommendation aimed to systematically review the evidence on benefits and harms of (1) screening for abnormal blood glucose and type 2 diabetes and (2) interventions for prediabetes or type 2 diabetes that was screen detected or recently diagnosed for populations and settings relevant to primary care in the United States.
The lower baseline age for screening, which carries a B grade, is a "major change" from the 2015 final USPSTF recommendation in this clinical area, said Chien-Wen Tseng, a task force member and research director in the department of family medicine and community health at the University of Hawaii John A. Burns School of Medicine. She added that changes in epidemiological data prompted the revised recommendation.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.